Found "Health Policies": 992 results
How Many People Experience Unsafe Medical Care in Thailand, and How Much Does It Cost under Universal Coverage Scheme?
Adverse events and medical harm comprise major health concerns for people all over the world, including Thailand. The prevalence and burden of medical harm must always be monitored, and a voluntary database should not be used to represent national value. The purpose of this study is to estimate the
Cost-utility analysis of treatment for prevention of osteoporotic fractures
Background: Osteoporosis, a reduction in bone strength, is one of the most significant factors contributing to fractures, particularly in postmenopausal women. It affects not only patients’ life expectancy and quality of life, but also household expenditure on healthcare costs. Various screening methods to identify the risk of developing osteopo
A study of feasibility of investing and access to spirometry service in community hospitals
Spirometry is a pulmonary function test that measures the volume of air exhaled quickly and strongly to assess how well the lung works. Spirometry is a gold standard of diagnosis, which distinguishes between chronic obstructive pulmonary disease (COPD) and asthma. Spirometry, moreover, is used to monitor disease progression, follow up treatment re
Groundwork: Pre-Conditions for Successful Healthcare Priority Setting
The Groundworks Project is a dialogue set up between industry representatives and health systems representatives of LMICs spanning a timeframe of 12 months and including three workshops. The first workshop focuses on agenda setting between a core group of representatives. The second workshop takes on a national perspective and discusses the context
Photo Album HTAsialink 2018
HTAsiaLink 20188-11 May 2018, Chiang Mai, ThailandMore than 200 participants from over 30 HTA organizations and other academic and policy making agencies across the global joined this conference!The themes of this years’ conference is Testing Treatments: Strengthening HTA for better healthcare.For
A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings
Abstract
Real-world effectiveness studies are important for monitoring performance of COVID-19 vaccination programmes and informing COVID-19 prevention and control policies. We aimed to synthesise methodological approaches used in COVID-19 vaccine effectiveness studies, in order to evaluate which
Full report: Guidance on use of modelling for policy responses to COVID-19
As COVID-19 spreads worldwide, national (and sub-national) governments and development partners are making use of a rapidly growing body of evidence to develop policies mitigating against this devastating pandemic. Mathematical models and computational simulation models play a unique role to inform
Preliminary recommendations on the establishment of a regional centre for infectious disease control in ASEAN
“United we stand, divided we fall” is a Thai idiom used to exemplify the importance of staying united and of teamwork and common interests. This idiom is reaffirmed in the context of the COVID-19 pandemic, shown in the global nature of catastrophe and the shared prospects of recovery. However, p
Experience in Using HTA for Expanding UHC Benefit Package to Cover Rare Diseases and High-Cost Drugs among Seven Middle and High-Income Countries: A targeted literature review
This policy brief provides a summary of a recent review of the definition of rare diseases, high cost and how HTA has been used in the case of rare diseases in seven countries. The countries were purposively selected based on them having established HTA policies and availability of resources in the
Assessing alternative measures for controlling drug prices (in Thai language)
The study suggests that the price of patented medicine in Thailand should be controlled based on equity pricing and outcome pricing. Equity pricing can be estimated from the international reference price and outcome pricing can be evaluated from therapeutic referencing or the pharmacoeconomic price. Moreover, in a case study of 7 medicines granted
10 / Page